Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 18B (ANKRD18B) is a protein-coding gene encoding a member of the ankyrin repeat domain-containing protein family, which typically function in mediating protein–protein interactions and structural scaffolding. In particular, ANKRD18B acts as a critical scaffolding protein in retinal Mueller cells, being essential for maintaining structural integrity of the retina[3]. It is associated with diseases such as ovary serous adenocarcinoma and large intestine adenocarcinoma, although mechanistic and functional data for ANKRD18B remain limited[5]. ANKRD18B is mainly classified as an "other" protein (scaffolding protein), not a canonical drug target like a receptor, enzyme, or transporter[2][5]. No evidence currently establishes ANKRD18B as a direct therapeutic target, nor are there known drugs or mechanistic strategies specifically targeting it[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 18B (ANKRD18B).